Need pharma insights? Register for Evaluate Discovery
Menu
Menu
When bringing new assets into your pipeline, you need a deep understanding of their potential clinical and commercial differentiation, their competitive landscape, and the overall dynamics of the market they’re in.
Gain invaluable insights into success rates, project timelines, R&D spending, and patient costs. By leveraging our platform, you can conduct thorough assessments of potential within therapy areas, identify unmet needs from patient and market perspectives, and strategically position yourself against your competitors.
Discover which products are primed to deliver significant ROI, using analysts’ forecasts to size the market at product and indication levels.
View pricing by drug type or company to understand revenue potential. Compare a target to similar assets and get a better idea of its growth trajectory.
Understand potential market by country. Confidently plan, prioritise, and validate your geographic sales territories.
Utilise analyst forecasts at a product and indication level, through Consensus Forecasts and Sales by Indication (SbI) Forecasts, to understand potential market size and identify growth-driving products based on financial market indicators.
Conduct precise market sizing, including early-stage and privately-owned assets, using NPV modeling that incorporates analyst forecasts, allowing for the identification of growth-driven products or therapy areas.
Establish a foundation for making confident forecast-based business decisions by utilising the insights gained from sizing market potential, profiling patient segments, and understanding the market landscape.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Find and validate pharma opportunities with a robust assessment of market fit, risk, uptake and sales forecasts, and more.
Know which opportunities and markets offer the highest growth potential. Focus your resources strategically.
Build a better understanding of your growth drivers and product differentiators with a clear analysis of market dynamics, trends, unmet needs, and competitors.
Determine the true worth and potential of assets, score high-value opportunities, and make confident licensing or acquisition decisions.
Triangulate internal assumptions and power your allocation strategy with external benchmarking data across the R&D landscape.
Understand the context with data-driven insights
If there’s one thing that the experts at Evaluate love, it’s rummaging around in data to identify trends in the pharma market. One area that is always fascinating to explore...
September 27, 2024
Volume is up but value is down. That’s the headline of the dealmaking scene for the first half of 2024. There’s not been a mega-merger in the vein of 2023’s...
August 8, 2024
Kelly Chamberlain may not have been at the company very long, but that didn’t stop me swooping in to find out a little more about her. Kelly has joined Norstella,...
If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re...
July 24, 2024
There is no shortage of discussion about the opportunities presented by artificial intelligence and AI in the pharma industry. 50% of global healthcare companies plan to implement AI strategies by...
Evaluate’s annual World Preview report is a must-read for many in the pharma industry. Each year, we pull together some of our key pharma forecasts to build a picture of...
